Gao has more than 25 years of experience in leading various functions including finance, audit, investment, project management, compliance and board office.
Partnership network combines the power of automated CRISPR cell line engineering with phenotypic, functional and multi-omic assays to optimize research work.
Selection of the proper technology can make the difference between development success or failure. Learn more in this whitepaper from Lonza Pharma & Biotech.
With applications for investigating functional comparability of an originator and biosimilar
Nicolas Fourrier, Director Biomarker and Biopharmaceutical Testing, SGS; Abhishek Saharia, Director of Cell-Based Assays & Biologics, DiscoverX; Fiona Greer, Global Director, Biopharma Services Development, Life Sciences, SGS11.30.16